BGI Genomics and Reword have reached a strategic cooperation.

According to news from BGI Genomics, recently, BGI Genomics and Shenzhen Revo Life Science Co., Ltd. have reached a strategic cooperation agreement and announced the official release of a fully automated solution for single-cell workflows. The two parties will collaborate on products related to single-cell suspension preparation instruments, leveraging BGI Genomics' established global channels and customer system to engage in in-depth cooperation in China and some regions in the Asia-Pacific and Europe, jointly promoting the international placement and business expansion of core products.